AKT1 and neoplasm: It is hypothesized that GLP-1 RAs act here as modulators, exerting a negative feedback inhibition on the hyperactive PI3K/Akt signal, or by diverting receptor activation toward other pathways like AMPK, which induces cell cycle arrest and apoptosis in tumour contexts.